The ingredient, explained

Alpha-arbutin

A specific arbutin form studied in a topical pigmentation combination.

AntioxidantTyrosinase inhibitor / brighteningBleachingSkin conditioning

Explore connections

Ingredient guide

What it is and what it does

4-Hydroxyphenyl-alpha-D-glucopyranoside

About this ingredient: EU CosIng ingredient registry (via Open Beauty Facts taxonomy) ↗

Antioxidant: Limits oxidation, including deterioration of formulation ingredients. This label alone does not show a clinical antioxidant effect in skin.
Tyrosinase inhibitor / brightening: Research category for changes in pigmentation or uneven skin tone. The label does not establish that a finished product changes pigmentation.
Bleaching: A technical role associated with lightening hair or skin.
Skin conditioning: A broad cosmetic role for maintaining skin condition. It does not identify a particular clinical benefit.

Function definitions: European Commission ingredient function definitions (SCCNFP/0299/00, pages 16 to 20) ↗ · Original niacinamide study: Pigmentation and hyperpigmented spots ↗

Registry functions describe possible formulation roles, not results for a finished product. A dictionary entry is not an approval or a safety assessment.

A closer look

What the research shows

Human research on a combination

Thirty participants with melasma entered a 12-week split-face pilot trial of 5% alpha-arbutin plus 2% kojic acid versus a triple-combination medicinal cream. Objective pigmentation outcomes did not significantly differ between sides; physician assessment favoured the triple-combination cream.

What this does not tell us

Twenty-seven participants completed the trial and all used sunscreen. The combination cannot isolate alpha-arbutin. Different application frequencies, a small sample and four weeks of follow-up do not establish equivalence or long-term recurrence prevention.

Sources for this summary. PubMed 39555866 ↗

Research review checked Sep 30, 2026

Selected primary sources were reviewed for the existing research brief on 30 September 2026, with exact ingredient, route and combination limitations recorded. This was a bounded editorial review, not a systematic search.

Ingredient research is not proof that a product containing this ingredient works.